Multiple case reports have confirmed PSMA tracer uptake in patients with soft tissue sarcoma, with uptake ranging from mild to intense in e.g. liposarcoma, undifferentiated pleomorphic sarcoma, angiosarcoma and leiomyosarcoma [11]. This evidence concerns the gene FOLH1 and leiomyosarcoma.